Skip to main content
Top
Published in: Orphanet Journal of Rare Diseases 1/2021

Open Access 01-12-2021 | Research

Mutation of c.244G>T in NR5A1 gene causing 46, XY DSD by affecting RNA splicing

Authors: Bingqing Yu, Yinjie Gao, Jiangfeng Mao, Xi Wang, Min Nie, Xueyan Wu

Published in: Orphanet Journal of Rare Diseases | Issue 1/2021

Login to get access

Abstract

Objective

To identify the pathogenic mechanism of the c.244G>T mutation in NR5A1 gene found in a Chinese patient with 46, XY disorders of sex development (DSD). Subjects and methods: Genomic DNA was extracted from a Chinese 46, XY DSD patient. Targeted next-generation and Sanger sequencing were performed to investigate and validate the gene mutation causing 46, XY DSD, respectively. In silico tools were used to predict the pathogenicity of the variant. Dual luciferase reporter gene assay and minigene splicing reporter assay were used to identify the pathogenicity of the variant.

Results

A novel heterozygous variant, c.244G>T (p.Ala82Ser), in NR5A1 gene was detected in the 46, XY DSD patient. Four of five silico tools predicting pathogenicity of missense variants indicated that the variant was pathogenic. However, in vitro functional study showed that p.Ala82Ser did not affect the transcriptional activity of NR5A1. In silico tools predicting the potential splicing loci revealed that c.244G>T led to aberrant splicing of NR5A1 RNA. Minigene splicing reporter assay confirmed that c.244G>T resulted in the deletion of exon2 or deletion of 19 nucleotides in 3′ end of exon2.

Conclusions

Mutation of c.244G>T in NR5A1 results in 46, XY DSD by inducing abnormal splicing of NR5A1 RNA instead of amino acid substitution of NR5A1.
Literature
1.
go back to reference Ahmed SF, Bashamboo A, Lucas-Herald A, McElreavey K. Understanding the genetic aetiology in patients with XY DSD. Br Med Bull. 2013;106:67–89.CrossRef Ahmed SF, Bashamboo A, Lucas-Herald A, McElreavey K. Understanding the genetic aetiology in patients with XY DSD. Br Med Bull. 2013;106:67–89.CrossRef
2.
go back to reference Hughes IA, Houk C, Ahmed SF, Lee PA. Consensus statement on management of intersex disorders. J Pediatr Urol. 2006;2:148–62.CrossRef Hughes IA, Houk C, Ahmed SF, Lee PA. Consensus statement on management of intersex disorders. J Pediatr Urol. 2006;2:148–62.CrossRef
3.
go back to reference Audi L, Ahmed SF, Krone N, Cools M, McElreavey K, Holterhus PM, et al. Genetics in endocrinology: approaches to molecular genetic diagnosis in the management of differences/disorders of sex development (DSD): position paper of EU COST Action BM 1303 ‘DSDnet.’ Eur J Endocrinol. 2018;179:R197-r206.CrossRef Audi L, Ahmed SF, Krone N, Cools M, McElreavey K, Holterhus PM, et al. Genetics in endocrinology: approaches to molecular genetic diagnosis in the management of differences/disorders of sex development (DSD): position paper of EU COST Action BM 1303 ‘DSDnet.’ Eur J Endocrinol. 2018;179:R197-r206.CrossRef
4.
go back to reference El-Khairi R, Achermann JC. Steroidogenic factor-1 and human disease. Semin Reprod Med. 2012;30:374–81.CrossRef El-Khairi R, Achermann JC. Steroidogenic factor-1 and human disease. Semin Reprod Med. 2012;30:374–81.CrossRef
5.
go back to reference Hoivik EA, Lewis AE, Aumo L, Bakke M. Molecular aspects of steroidogenic factor 1 (SF-1). Mol Cell Endocrinol. 2010;315:27–39.CrossRef Hoivik EA, Lewis AE, Aumo L, Bakke M. Molecular aspects of steroidogenic factor 1 (SF-1). Mol Cell Endocrinol. 2010;315:27–39.CrossRef
6.
go back to reference Colson C, Aubry E, Cartigny M, Remy AA, Franquet H, Leroy X, et al. SF1 and spleen development: new heterozygous mutation, literature review and consequences for NR5A1-mutated patient’s management. Clin Genet. 2017;92:99–103.CrossRef Colson C, Aubry E, Cartigny M, Remy AA, Franquet H, Leroy X, et al. SF1 and spleen development: new heterozygous mutation, literature review and consequences for NR5A1-mutated patient’s management. Clin Genet. 2017;92:99–103.CrossRef
7.
go back to reference Suntharalingham JP, Buonocore F, Duncan AJ, Achermann JC. DAX-1 (NR0B1) and steroidogenic factor-1 (SF-1, NR5A1) in human disease. Best Pract Res Clin Endocrinol Metab. 2015;29:607–19.CrossRef Suntharalingham JP, Buonocore F, Duncan AJ, Achermann JC. DAX-1 (NR0B1) and steroidogenic factor-1 (SF-1, NR5A1) in human disease. Best Pract Res Clin Endocrinol Metab. 2015;29:607–19.CrossRef
8.
go back to reference Goursaud C, Mallet D, Janin A, Menassa R, Tardy-Guidollet V, Russo G, et al. Aberrant splicing is the pathogenicity mechanism of the p.Glu314Lys Variant in CYP11A1 Gene. Front Endocrinol (Lausanne). 2018;9:491.CrossRef Goursaud C, Mallet D, Janin A, Menassa R, Tardy-Guidollet V, Russo G, et al. Aberrant splicing is the pathogenicity mechanism of the p.Glu314Lys Variant in CYP11A1 Gene. Front Endocrinol (Lausanne). 2018;9:491.CrossRef
9.
go back to reference Geng X, Liu Y, Ren X, Guan Y, Wang Y, Mao B, et al. Novel NTRK1 mutations in Chinese patients with congenital insensitivity to pain with anhidrosis. Mol Pain. 2018;14:1744806918781140.CrossRef Geng X, Liu Y, Ren X, Guan Y, Wang Y, Mao B, et al. Novel NTRK1 mutations in Chinese patients with congenital insensitivity to pain with anhidrosis. Mol Pain. 2018;14:1744806918781140.CrossRef
10.
go back to reference Fraile-Bethencourt E, Valenzuela-Palomo A, Diez-Gomez B, Acedo A, Velasco EA. Identification of eight spliceogenic variants in BRCA2 Exon 16 by minigene assays. Front Genet. 2018;9:188.CrossRef Fraile-Bethencourt E, Valenzuela-Palomo A, Diez-Gomez B, Acedo A, Velasco EA. Identification of eight spliceogenic variants in BRCA2 Exon 16 by minigene assays. Front Genet. 2018;9:188.CrossRef
11.
go back to reference Lin L, Achermann JC. Steroidogenic factor-1 (SF-1, Ad4BP, NR5A1) and disorders of testis development. Sex Dev. 2008;2:200–9.CrossRef Lin L, Achermann JC. Steroidogenic factor-1 (SF-1, Ad4BP, NR5A1) and disorders of testis development. Sex Dev. 2008;2:200–9.CrossRef
12.
go back to reference Stenson PD, Mort M, Ball EV, Howells K, Phillips AD, Thomas NS, et al. The human gene mutation database: 2008 update. Genome Med. 2009;1:13.CrossRef Stenson PD, Mort M, Ball EV, Howells K, Phillips AD, Thomas NS, et al. The human gene mutation database: 2008 update. Genome Med. 2009;1:13.CrossRef
13.
go back to reference Thusberg J, Olatubosun A, Vihinen M. Performance of mutation pathogenicity prediction methods on missense variants. Hum Mutat. 2011;32:358–68.CrossRef Thusberg J, Olatubosun A, Vihinen M. Performance of mutation pathogenicity prediction methods on missense variants. Hum Mutat. 2011;32:358–68.CrossRef
14.
go back to reference Gnad F, Baucom A, Mukhyala K, Manning G, Zhang Z. Assessment of computational methods for predicting the effects of missense mutations in human cancers. BMC Genomics. 2013;14(Suppl 3):S7.CrossRef Gnad F, Baucom A, Mukhyala K, Manning G, Zhang Z. Assessment of computational methods for predicting the effects of missense mutations in human cancers. BMC Genomics. 2013;14(Suppl 3):S7.CrossRef
15.
go back to reference Rodrigues C, Santos-Silva A, Costa E, Bronze-da-Rocha E. Performance of in silico tools for the evaluation of UGT1A1 missense variants. Hum Mutat. 2015;36:1215–25.CrossRef Rodrigues C, Santos-Silva A, Costa E, Bronze-da-Rocha E. Performance of in silico tools for the evaluation of UGT1A1 missense variants. Hum Mutat. 2015;36:1215–25.CrossRef
16.
go back to reference Luxembourg B, D’Souza M, Körber S, Seifried E. Prediction of the pathogenicity of antithrombin sequence variations by in silico methods. Thromb Res. 2015;135:404–9.CrossRef Luxembourg B, D’Souza M, Körber S, Seifried E. Prediction of the pathogenicity of antithrombin sequence variations by in silico methods. Thromb Res. 2015;135:404–9.CrossRef
17.
go back to reference Zou M, Baitei EY, Alzahrani AS, Parhar RS, Al-Mohanna FA, Meyer BF, et al. Mutation prediction by PolyPhen or functional assay, a detailed comparison of CYP27B1 missense mutations. Endocrine. 2011;40:14–20.CrossRef Zou M, Baitei EY, Alzahrani AS, Parhar RS, Al-Mohanna FA, Meyer BF, et al. Mutation prediction by PolyPhen or functional assay, a detailed comparison of CYP27B1 missense mutations. Endocrine. 2011;40:14–20.CrossRef
18.
go back to reference Soukarieh O, Gaildrat P, Hamieh M, Drouet A, Baert-Desurmont S, Frebourg T, et al. Exonic splicing mutations are more prevalent than currently estimated and can be predicted by using in silico tools. PLoS Genet. 2016;12:e1005756.CrossRef Soukarieh O, Gaildrat P, Hamieh M, Drouet A, Baert-Desurmont S, Frebourg T, et al. Exonic splicing mutations are more prevalent than currently estimated and can be predicted by using in silico tools. PLoS Genet. 2016;12:e1005756.CrossRef
19.
go back to reference Baralle D, Buratti E. RNA splicing in human disease and in the clinic. Clin Sci (Lond). 2017;131:355–68.CrossRef Baralle D, Buratti E. RNA splicing in human disease and in the clinic. Clin Sci (Lond). 2017;131:355–68.CrossRef
20.
go back to reference Ito K, Patel PN, Gorham JM, McDonough B, DePalma SR, Adler EE, et al. Identification of pathogenic gene mutations in LMNA and MYBPC3 that alter RNA splicing. Proc Natl Acad Sci USA. 2017;114:7689–94.CrossRef Ito K, Patel PN, Gorham JM, McDonough B, DePalma SR, Adler EE, et al. Identification of pathogenic gene mutations in LMNA and MYBPC3 that alter RNA splicing. Proc Natl Acad Sci USA. 2017;114:7689–94.CrossRef
21.
go back to reference Baralle D, Baralle M. Splicing in action: assessing disease causing sequence changes. J Med Genet. 2005;42:737–48.CrossRef Baralle D, Baralle M. Splicing in action: assessing disease causing sequence changes. J Med Genet. 2005;42:737–48.CrossRef
22.
go back to reference Shapiro MB, Senapathy P. RNA splice junctions of different classes of eukaryotes: sequence statistics and functional implications in gene expression. Nucl Acids Res. 1987;15:7155–74.CrossRef Shapiro MB, Senapathy P. RNA splice junctions of different classes of eukaryotes: sequence statistics and functional implications in gene expression. Nucl Acids Res. 1987;15:7155–74.CrossRef
23.
go back to reference Krawczak M, Thomas NS, Hundrieser B, Mort M, Wittig M, Hampe J, et al. Single base-pair substitutions in exon-intron junctions of human genes: nature, distribution, and consequences for mRNA splicing. Hum Mutat. 2007;28:150–8.CrossRef Krawczak M, Thomas NS, Hundrieser B, Mort M, Wittig M, Hampe J, et al. Single base-pair substitutions in exon-intron junctions of human genes: nature, distribution, and consequences for mRNA splicing. Hum Mutat. 2007;28:150–8.CrossRef
24.
go back to reference Yu B, Liu Z, Gao Y, Mao J, Wang X, Hao M, et al. Novel NR5A1 mutations found in Chinese patients with 46, XY disorders of sex development. Clin Endocrinol (Oxf). 2018;89:613–20.CrossRef Yu B, Liu Z, Gao Y, Mao J, Wang X, Hao M, et al. Novel NR5A1 mutations found in Chinese patients with 46, XY disorders of sex development. Clin Endocrinol (Oxf). 2018;89:613–20.CrossRef
Metadata
Title
Mutation of c.244G>T in NR5A1 gene causing 46, XY DSD by affecting RNA splicing
Authors
Bingqing Yu
Yinjie Gao
Jiangfeng Mao
Xi Wang
Min Nie
Xueyan Wu
Publication date
01-12-2021
Publisher
BioMed Central
Published in
Orphanet Journal of Rare Diseases / Issue 1/2021
Electronic ISSN: 1750-1172
DOI
https://doi.org/10.1186/s13023-021-02002-0

Other articles of this Issue 1/2021

Orphanet Journal of Rare Diseases 1/2021 Go to the issue